Myriad Genetics, Inc. (MYGN) Stock is more thoughtful than you think

Piper Sandler raised the price target for the Myriad Genetics, Inc. (NASDAQ:MYGN) stock to “a Neutral”. The rating was released on December 21, 2023, according to finviz. The research report from Guggenheim has initiated the stock to Buy, with a price target set at $23. The stock was initiated by Wolfe Research, who disclosed in […]

Is Myriad Genetics, Inc. (MYGN) Stock A Better Investment Than Its Rivals?

Piper Sandler raised the price target for the Myriad Genetics, Inc. (NASDAQ:MYGN) stock to “a Neutral”. The rating was released on December 21, 2023, according to finviz. The research report from Guggenheim has initiated the stock to Buy, with a price target set at $23. The stock was initiated by Wolfe Research, who disclosed in […]